Implementation of cabotegravir and rilpivirine long-acting (CAB plus RPV LA): primary results from the CAB plus RPV Implementation Study in European Locations (CARISEL)

被引：0

作者：

Van Welzen, B. ^{[1
]}

Vandekerckhove, L. ^{[2
,3
]}

Jonsson-Oldenbuettel, C. ^{[4
]}

Hocqueloux, L. ^{[5
]}

Ait-Khaled, M. ^{[6
]}

Bontempo, G. ^{[7
]}

DeMoor, R. ^{[8
]}

Scherzer, J. ^{[9
]}

D'Amico, R. ^{[10
]}

Barnes, N. ^{[11
]}

Hadi, M. ^{[11
]}

Low, E. ^{[11
]}

Anand, S. ^{[11
]}

Czarnogorski, M. ^{[12
]}

Gutner, C. ^{[13
]}

机构：

[1] Univ Med Ctr Utrecht, Internal Med & Infect Dis, Utrecht, Netherlands

[2] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium

[3] Univ Ghent, HIV Cure Res Ctr, Ghent, Belgium

[4] Munich Res GmbH, Med Versorgungszentrum Munchen Goethepl, HIV Res & Clin Care Ctr, Munich, Germany

[5] Hop Source Orleans, Infect & Trop Dis, Ctr Hosp Reg Orleans, Orleans, France

[6] ViiV Healthcare Ltd, Clin Sci, R&D, Brentford, England

[7] ViiV Healthcare Ltd, Res & Dev, Branford, CT USA

[8] GlaxoSmithKline, R&D Biostatist, Collegeville, PA USA

[9] ViiV Healthcare GmbH, Global Hlth Outcomes, Munich, Germany

[10] ViiV Healthcare Ltd, Res & Dev, Durham, NC USA

[11] Evidera, Patient Cent Res, London, England

[12] ViiV Healthcare, Global Med Sci, Durham, NC USA

[13] ViiV Healthcare Ltd, Global Med Sci Innovat & Implementat Sci, Durham, NC USA

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2022年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P069

引用

页码：71 / 72

页数：2

共 50 条

[1] Perceptions of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) from patients in the CAB plus RPV implementation study in European locations (CARISEL)
Lutz, Thomas
Jeanmaire, Eliette
Portilla, Joaquin
Scherzer, Jenny
Trehan, Rekha
Pascaul-Bernaldez, Miguel
DeMoor, Rebecca
Ait-Khaled, Mounir
Hadi, Monica
Anand, Savita Bakhshi
Low, Emma L.
Czarnogorski, Maggie
Gutner, Cassidy A.
Neumann, Jeanette
[J]. HIV MEDICINE, 2023, 24 : 20 - 21
[2] Perceptions of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) from patients in the CAB plus RPV Implementation Study in European Locations (CARISEL)
Lutz, T.
Jeanmaire, E.
Portilla, J.
Scherzer, J.
Trehan, R.
Pascual-Bernaldez, M.
DeMoor, R.
Ait-Khaled, M.
Hadi, M.
Anand, S.
Low, E.
Czarnogorski, M.
Gutner, C.
[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 117 - 118
[3] Overcoming barriers and achieving optimal implementation of cabotegravir and rilpivirine long-acting (CAB plus RPV LA): staff study participant (SSP) results from the CAB plus RPV Implementation Study in European Locations (CARISEL)
Slama, L.
Crusells-Canales, M.
Olalla, J.
DeMoor, R.
Ait-Khaled, M.
Dakhia, S.
Van Mechelen, H.
Hamilton, A.
Hadi, M.
Filipenko, D.
Brown, F.
Low, E.
Gutner, C.
Czarnogorski, M.
[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 111 - 112
[4] Perspectives on the acceptability, appropriateness, feasibility, barriers, and facilitators from patients receiving cabotegravir plus rilpivirine long-acting injectable treatment (CAB plus RPV LA): interim results from the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL)
Hocqueloux, L.
Gutner, C.
DeMoor, R.
Gill, M.
Trehan, R.
D'Amico, R.
Tomkins, S.
Schroeder, M.
Bontempo, G.
Ait-Khaled, M.
Hadi, M.
Anand, S. Bakhshi
Low, E. L.
Jeanmaire, E.
Crusells Canales, M.
Vandekerckhove, L.
Bonnet, F.
Olalla Sierra, J.
Czarnogorski, M.
[J]. HIV MEDICINE, 2021, 22 : 99 - 99
[5] Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL): examining health care staff attitudes during a hybrid III implementation-effectiveness trial implementing cabotegravir plus rilpivirine long-acting injectable (CAB plus RPV LA) for people living with HIV (PLHIV)
Gutner, C.
Dakhia, S.
Gill, M.
Pascual-Bernaldez, M.
Hernandez, B.
Rami, A.
Portilla, J.
Lutz, T.
van der Valk, M.
Florence, E.
Barnes, N.
Cooper, O.
Filipenko, D.
Hamilton, A.
Bosse, M.
Czarnogorski, M.
[J]. HIV MEDICINE, 2021, 22 : 114 - 115
[6] Efficacy, safety and implementation outcomes of Cabotegravir plus Rilpivirine long-acting by country in the Cabotegravir and rilpivirine implementation study in European locations (CARISEL)
Jonsson-Oldenbuettel, C.
Ghosn, J.
Sierra, J. Olalla
van der Valk, M.
Lutz, T.
Belkhir, L.
van Welzen, B. J.
Hove, K.
Ait-Khaled, M.
DeMoor, R.
Bontempo, G.
Latham, C. L.
Ngenzi, B.
Okoli, C.
Gutner, C. A.
Iyer, S.
Gill, M.
Czarnogorski, M.
D'Amico, R.
van Wyk, J.
[J]. HIV MEDICINE, 2023, 24 : 193 - 195
[7] The use and utility of toolkits in supporting cabotegravir plus rilpivirine long-acting implementation in the CARISEL (Cabotegravir And Rilpivirine Implementation Study in European Locations) study
Trehan, Rekha
Gutner, Cassidy
Okoli, Chinyere
Ghosn, Jade
Vera, Francisco
Florence, Eric
Lutz, Thomas
van der Valk, Marc
Czarnogorski, Maggie
[J]. HIV MEDICINE, 2023, 24 : 93 - 93
[8] Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics
Olalla, Julian
Gutner, Cassidy
Pascual-Bernaldez, Miguel
Hernandez, Beatriz
Dakhia, Samia
Slama, Laurence
Crusells Canales, Maria Jose
Lutz, Thomas
van der Valk, Mark
van Welzen, Berend
Florence, Eric
Barnes, Nicola
Cooper, Owen
Filipenko, Dina
Czarnogorski, Maggie
[J]. HIV MEDICINE, 2022, 23 : 27 - 28
[9] Initiation of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) regimen across five European countries in CARISEL during the COVID-19 pandemic
Czarnogorski, Maggie
Wang, Yongwei
Tomkins, Ms. Susan
Yu, Ren
Barnes, Nicola
Patel, Parul
Gill, Martin
Ait-Khaled, Mounir
Gutner, Cassidy
Moorhouse, Michelle
D'Amico, Ronald
Bosse, Matthew
[J]. HIV MEDICINE, 2021, 22 : 5 - 6
[10] Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study
Gutner, Cassidy A.
van der Valk, Marc
Portilla, Joaquin
Jeanmaire, Eliette
Belkhir, Leila
Lutz, Thomas
Demoor, Rebecca
Trehan, Rekha
Scherzer, Jenny
Pascual-Bernaldez, Miguel
Ait-Khaled, Mounir
Hernandez, Beatriz
de Ruiter, Annemiek
Anand, Savita Bakhshi
Low, Emma L.
Hadi, Monica
Barnes, Nicola
Sevdalis, Nick
Mohammed, Perry
Czarnogorski, Maggie
[J]. JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2024, 23

← 1 2 3 4 5 →